Perianal Involvement in Crohn’s Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
Pegloticase Safe for Dialysis Patients With Gout Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
Serious Infections Still Common in Vasculitis Cyclophosphamide induction was riskier than rituximab Mar 23, 2021
What to Tell Patients With Rheumatic/Musculoskeletal Diseases About COVID Vaccines New guidance from the American College of Rheumatology Mar 19, 2021
Vasculitis Rates Rise With Earth's Latitude Highest rates for giant cell arteritis seen in Scandinavia, lowest in Hong Kong Mar 17, 2021
Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemia Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
Combo Therapy Boosts Response in Uncontrolled Gout "Markedly higher" rate than with pegloticase alone Mar 02, 2021
Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
Anakinra for Gout Flares: Is There a Role? IL-1 blockade was not superior to triamcinolone, but does have advantages Feb 23, 2021
Lung Hemorrhage in Lupus: Which Patients Die? Risk factors include older age, longer disease duration, infection, and certain treatments Feb 20, 2021
Avacopan for ANCA Vasculitis: A New Treatment Paradigm? Remission rates not inferior to prednisone -- the "unthinkable" achieved Feb 17, 2021
Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home But some find science-by-press-release troubling Jan 26, 2021
IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
Copay Assistance Programs Help Patients but Confuse Them Too Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
Staying Safe in Lupus: Monitor Hydroxychloroquine Levels Limit the retinopathy risk while maintaining anti-thrombotic protection, study suggests Jan 11, 2021
Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
PET Scans Reveal Vascular Inflammation In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
Who Flares When SLE Patients Stop Hydroxychloroquine? Flares more likely among minorities, younger patients, and those taking steroids Jan 05, 2021
Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
More Evidence Early Mortality Persists in IBD Canadian study shows treatment advances haven't erased lifespan deficit Nov 09, 2020
COVID Complications Common with Rheumatic Disease Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
Rinvoq for RA: Benefits Persist Beyond 1 Year Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
Upadacitinib, Abatacept Go Head to Head in RA And the winner is... both, depending on whether efficacy or safety is the main criterion Oct 14, 2020
Depression and Biologic Use in Arthritis: Chicken or Egg? Relationship appears to be bi-directional, researchers say Oct 02, 2020
Novel Biologic Promising in Mid-Stage Scleroderma Trial Significant differences seen at week 24 for the agent versus placebo on background therapy Sep 28, 2020
COVID-19 Storms: Bradykinin In, Cytokine Out? Papers poke holes in cytokine storm as gene expression study offers a new theory Sep 11, 2020
Mepolizumab Offers Relief for Chronic Sinus Trouble Anti-IL5 biologic cut polyp size, need for surgery in chronic rhinosinusitis with nasal polyps Sep 10, 2020
Capsaicin Injection Improves Knee OA Pain Investigational treatment targets capsaicin receptor to inactivate local pain fibers Sep 06, 2020
Novel Form of Muscle Relaxant Shows Benefit Tolperisone may help pain from acute back spasms without causing drowsiness Sep 05, 2020
Joint Effusion Protective in Hand OA Unlike synovitis, which was linked with both pain and progression Sep 03, 2020
